A Multicenter Comparative Trial of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies

Phase 4

Completed

• Conditions: Epilepsy
• Interventions: Drug: Zonisamide; Drug: Topiramate

• Registration Number: NCT00154076
• Lead Sponsor: Eisai Korea Inc.

Brief Summary

To assess the efficacy and safety of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies

Detailed Description

Not available

Study Timeline

• Study Start: 2005-09
• Study First Submitted: 2005-09-08
• Study First Submitted QC: 2005-09-08
• Study First Posted: 2005-09-12
• Primary Completion: 2008-08
• Study Completion: 2008-12
• Status Verified: 2009-08
• Last Update Submitted: 2009-09-01
• Last Update Posted: 2009-09-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 140

Inclusion Criteria

Not provided

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
1	Zonisamide	-
2	Topiramate	-

Primary Outcome Measures

Name	Time	Method
Seizure frequency	2, 4, 8, 12, 16, 20, 24 weeks

Secondary Outcome Measures

Name	Time	Method
Cognitive function	0, 24 weeks

Trial Locations

Locations (1)

Daegu Catholic University Medical Center; 🇰🇷 Daegu, Korea, Republic of